335 related articles for article (PubMed ID: 28189362)
1. Patient-centered Outcomes with Concomitant Use of Proton Pump Inhibitors and Other Drugs.
Shamliyan TA; Middleton M; Borst C
Clin Ther; 2017 Feb; 39(2):404-427.e36. PubMed ID: 28189362
[TBL] [Abstract][Full Text] [Related]
2. Conflicting results between randomized trials and observational studies on the impact of proton pump inhibitors on cardiovascular events when coadministered with dual antiplatelet therapy: systematic review.
Melloni C; Washam JB; Jones WS; Halim SA; Hasselblad V; Mayer SB; Heidenfelder BL; Dolor RJ
Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):47-55. PubMed ID: 25587094
[TBL] [Abstract][Full Text] [Related]
3. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis.
Kwok CS; Jeevanantham V; Dawn B; Loke YK
Int J Cardiol; 2013 Aug; 167(3):965-74. PubMed ID: 22464478
[TBL] [Abstract][Full Text] [Related]
4. Is the concomitant use of clopidogrel and Proton Pump Inhibitors still associated with increased adverse cardiovascular outcomes following coronary angioplasty?: a systematic review and meta-analysis of recently published studies (2012 - 2016).
Bundhun PK; Teeluck AR; Bhurtu A; Huang WQ
BMC Cardiovasc Disord; 2017 Jan; 17(1):3. PubMed ID: 28056809
[TBL] [Abstract][Full Text] [Related]
5. Concomitant use of proton pump inhibitors and dual antiplatelet therapy for cardiovascular outcomes.
Mandurino-Mirizzi A; Leonardi S; Melloni C
Minerva Endocrinol; 2017 Sep; 42(3):228-237. PubMed ID: 27808485
[TBL] [Abstract][Full Text] [Related]
6. Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review.
Sherwood MW; Melloni C; Jones WS; Washam JB; Hasselblad V; Dolor RJ
J Am Heart Assoc; 2015 Oct; 4(11):. PubMed ID: 26514161
[TBL] [Abstract][Full Text] [Related]
7. [ANMCO/AIGO Intersocietary consensus document: Gastroprotection in patients receiving antiplatelet and/or anticoagulant drugs].
Abrignani MG; Zullo A; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Gatta L; Imazio M; Riccio E; Rossini R; Scotto Di Uccio F; Soncini M; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
G Ital Cardiol (Rome); 2020 Mar; 21(3):228-241. PubMed ID: 32100736
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents.
Farhat N; Fortin Y; Haddad N; Birkett N; Mattison DR; Momoli F; Wu Wen S; Krewski D
Crit Rev Toxicol; 2019 Mar; 49(3):215-261. PubMed ID: 31192763
[TBL] [Abstract][Full Text] [Related]
9. Effects of proton pump inhibitors on platelet function in patients receiving clopidogrel: a systematic review.
Kwok CS; Loke YK
Drug Saf; 2012 Feb; 35(2):127-39. PubMed ID: 22204719
[TBL] [Abstract][Full Text] [Related]
10. Review article: combination of clopidogrel and proton pump inhibitors: implications for clinicians.
Tran M; Tafreshi J; Pai RG
J Cardiovasc Pharmacol Ther; 2010 Dec; 15(4):326-37. PubMed ID: 20938037
[TBL] [Abstract][Full Text] [Related]
11. Inconsistencies surrounding the risk of adverse outcomes with concomitant use of clopidogrel and proton pump inhibitors.
Kwok CS; Loke YK
Expert Opin Drug Saf; 2012 Mar; 11(2):275-84. PubMed ID: 22288498
[TBL] [Abstract][Full Text] [Related]
12. Adverse cardiovascular effects of concomitant use of proton pump inhibitors and clopidogrel in patients with coronary artery disease: a systematic review and meta-analysis.
Huang B; Huang Y; Li Y; Yao H; Jing X; Huang H; Li J
Arch Med Res; 2012 Apr; 43(3):212-24. PubMed ID: 22564422
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of impact of proton pump inhibitors on antiplatelet effect of clopidogrel.
Chen M; Wei JF; Xu YN; Liu XJ; Huang DJ
Cardiovasc Ther; 2012 Oct; 30(5):e227-33. PubMed ID: 21884023
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor and clopidogrel interaction: fact or fiction?
Laine L; Hennekens C
Am J Gastroenterol; 2010 Jan; 105(1):34-41. PubMed ID: 19904241
[TBL] [Abstract][Full Text] [Related]
15. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO).
Abrignani MG; Gatta L; Gabrielli D; Milazzo G; De Francesco V; De Luca L; Francese M; Imazio M; Riccio E; Rossini R; Scotto di Uccio F; Soncini M; Zullo A; Colivicchi F; Di Lenarda A; Gulizia MM; Monica F
Eur J Intern Med; 2021 Mar; 85():1-13. PubMed ID: 33279389
[TBL] [Abstract][Full Text] [Related]
16. Proton-pump inhibitors in patients requiring antiplatelet therapy: new FDA labeling.
Johnson DA; Chilton R; Liker HR
Postgrad Med; 2014 May; 126(3):239-45. PubMed ID: 24918808
[TBL] [Abstract][Full Text] [Related]
17. Comparative risk of ischemic stroke among users of clopidogrel together with individual proton pump inhibitors.
Leonard CE; Bilker WB; Brensinger CM; Flockhart DA; Freeman CP; Kasner SE; Kimmel SE; Hennessy S
Stroke; 2015 Mar; 46(3):722-31. PubMed ID: 25657176
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet therapy and proton pump inhibition: cause for concern?
Depta JP; Bhatt DL
Curr Opin Cardiol; 2012 Nov; 27(6):642-50. PubMed ID: 23075823
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the antithrombotic effects of clopidogrel by proton pump inhibitors: facts or fancies?
Lettino M
Eur J Intern Med; 2010 Dec; 21(6):484-9. PubMed ID: 21111931
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
